Xirou T, Kabanarou SA, Gkizis I, Garnavou-Xirou C, Velissaris S, Theodossiadis P, Chatziralli I. Chronic central serous chorioretinopathy-like maculopathy as atypical presentation of chorioretinal folds. Case reports in ophthalmology. 2017;8:568–573.

Chatziralli I, Theodossiadis G, Moschos MM, Mitropoulos P, Theodossiadis P. Ranibizumab vs. Aflibercept for Macular Edema due to Central Retinal Vein Occlusion. Ophthalmology Retina. 2017;1:355–356.

Chatziralli I, Theodossiadis G, Theodossiadis P. Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:1459–1460.

Garnavou-Xirou C, Xirou T, Kabanarou S, Gkizis I, Velissaris S, Chatziralli I. Eccentric macular hole after pars plana vitrectomy for epiretinal membrane without internal limiting membrane peeling: A case report. Ophthalmology and therapy. 2017;6:391–395.

Moschos MM, Chatziralli I, Gazouli M, Brouzas D, Cennamo G, Eidenberger T, Forte R, Panzella L, Cesarano I, Napolitano A, et al. Contents Vol. 58, 2017. Ophthalmic Research. 2017;58:I–IV.

Moschos MM, Chatziralli I, Gazouli M, Brouzas D, Cennamo G, Eidenberger T, Forte R, Panzella L, Cesarano I, Napolitano A, et al. Acknowledgements to the Referees. Ophthalmic Research. 2017;58:243–243.

Moschos MM, Chatziralli I, Gazouli M, Brouzas D, Cennamo G, Eidenberger T, Forte R, Panzella L, Cesarano I, Napolitano A, et al. Front & Back Matter. Ophthalmic Research. 2017;58.

Karagiannis D, Chatziralli I, Kaprinis K, Georgalas I, Parikakis E, Mitropoulos P. Location of submacular hemorrhage as a predictor of visual outcome after intravitreal ranibizumab for age-related macular degeneration. Clinical interventions in aging. 2017;12:1829.

Chatziralli I, Theodossiadis P, Parikakis E, Dimitriou E, Xirou T, Theodossiadis G, Kabanarou SA. Dexamethasone intravitreal implant in diabetic macular edema: real-life data from a prospective study and predictive factors for visual outcome. Diabetes Therapy. 2017;8:1393–1404.

Chatziralli IP, Sergentanis TN. Ocular gene therapy for neovascular AMD: a new era?. The Lancet. 2017;390:2139–2140.

Gkizis I, Garnavou-Xirou C, Velissaris S, Kabanarou S, Chatziralli I, Kontou E, Xirou T. Enzymatic vitreolysis with ocriplasmin for symptomatic vitreomacular traction syndrome. Acta Ophthalmologica. 2017;95.

Moschos MM, Chatziralli I, Brouzas D, Gazouli M. Bax and bcl2 gene polymorphisms in rhegmatogenous retinal detachment. Ophthalmic research. 2017;58:227–230.

Chatziralli I, Chatzipantelis A, Dimitriou E, Mpourouki E, Saitakis G, Theodossiadis P. Refractive changes after anti-VEGF injections for diabetic macular edema. Acta Ophthalmologica. 2017;95.

Chatziralli I. Surgical management of diabetic macular edema–Against. Acta Ophthalmologica. 2017;95.

Xirou T, Kabanarou S, Gkizis I, Garnavou-Xirou C, Velissaris S, Chatziralli I. Eccentric macular hole after pars plana vitrectomy for epiretinal membrane without internal limiting membrane peeling. Acta Ophthalmologica. 2017;95.

Xirou T, Chatziralli I. Ocriplasmin in the treatment of vitreomacular traction–for. Acta Ophthalmologica. 2017;95.

Chatziralli I, Theodossiadis G, Brouzas D, Emfietzoglou I, Theodossiadis P. Optical Coherence Tomography Evolution in a Case of X-Linked Juvenile Retinoschisis: 15 Years of Follow-Up. Case reports in ophthalmology. 2017;8:459–464.

Chatziralli I, Theodossiadis G, Kabanarou SA, Theodossiadis P. Ranibizumab versus dexamethasone implant for central retinal vein occlusion: special remarks of the RANIDEX study. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:2077–2078.

Halkiadakis I, Chatziralli I, Drakos E, Katzakis M, Skouriotis S, Patsea E, Mitropoulos P, Kandarakis A. Causes and management of small pupil in patients with cataract. Oman journal of ophthalmology. 2017;10:220.

Chatziralli I, Theodossiadis G, Parikakis E, Mitropoulos PG, Theodossiadis P. Long-term anatomical and functional outcomes in patients with ischemic central retinal vein occlusion treated with anti-vascular endothelial growth factor agents. Ophthalmic research. 2017;58:203–208.

Chatziralli IP, Theodossiadis G, Dimitriadis P, Charalambidis M, Agorastos A, Migkos Z, Platogiannis N, Moschos MM, Theodossiadis P, Keryttopoulos P. The effect of vitamin E on oxidative stress indicated by serum malondialdehyde in insulin-dependent type 2 diabetes mellitus patients with retinopathy. The open ophthalmology journal. 2017;11:51.

Kabanarou SA, Xirou T, Mangouritsas G, Garnavou-Xirou C, Boutouri E, Gkizis I, Chatziralli I. Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration. Clinical interventions in aging. 2017;12:911.

Chatziralli I, Sergentanis TN, Crosby-Nwaobi R, Winkley K, Eleftheriadis H, Ismail K, Amiel SA, Sivaprasad S. Model for risk-based screening of diabetic retinopathy in people with newly-diagnosed type 2 diabetes mellitus. Investigative ophthalmology & visual science. 2017;58:BIO99–BIO105.

Chatziralli I, Santarelli M, Patrao N, Nicholson L, Zola M, Rajendram R, Hykin P, Sivaprasad S. Identification of time point to best define ‘sub-optimal response’following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data. Eye. 2017;31:1594–1599.

Chatziralli I, Theodossiadis G, Kabanarou SA, Parikakis E, Xirou T, Mitropoulos P, Theodossiadis P. Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the RANIDEX study. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:1899–1905.

Shin KU, Bae JH, Song SJ, Lee MY, Ozgonul C, Besirli CG, Bartov E, Marques FB, Alves C, Ribeiro I, et al. SIRCOVA-OFTARED Joined Congress Abstracts. Valencia (Spain), June 30-July 2, 2016: Abstracts. Ophthalmic Research. 2017;57:13–31.

Chatziralli I, Theodossiadis P, Nicholson L, Steel D. Advances in Vitreoretinal Interface Disorders. 2017.

Chatziralli I, Theodossiadis G, Brouzas D, Theodossiadis P. Incidence and evolution of subretinal precipitates in optic disc pit maculopathy. European journal of ophthalmology. 2017;27:769–773.

Chatziralli I, Kabanarou SA, Parikakis E, Chatzirallis A, Xirou T, Mitropoulos P. Risk factors for central serous chorioretinopathy: multivariate approach in a case-control study. Current Eye Research. 2017;42:1069–1073.

Ramu J, Chatziralli I, Yang Y, Menon G, Bailey C, Eckstein M, Hykin P, Sivaprasad S. Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema. Patient preference and adherence. 2017;11:579.

Moschos MM, Chatziralli I, Sioziou A, Gazouli M. Receptor of advanced glycation end products gene polymorphism and primary open-angle glaucoma. Ophthalmic research. 2017;58:81–84.

Chatziralli I, Theodossiadis G, Moschos MM, Mitropoulos P, Theodossiadis P. Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:1093–1100.

Papastavrou VT, Chatziralli I, McHugh D. Gas Tamponade for Retinectomy in PVR-Related Retinal Detachments: A Retrospective Study. Ophthalmology and therapy. 2017;6:161–166.

Chatziralli I, Theodossiadis G, Douvali M, Rouvas AA, Theodossiadis P. Eccentric macular hole after pars plana vitrectomy for idiopathic macular hole: a case report. Case reports in ophthalmology. 2017;8:116–119.

Chatziralli IP. The role of dyslipidemia control in the progression of diabetic retinopathy in patients with type 2 diabetes mellitus. Diabetes Therapy. 2017;8:209–212.

Chatziralli I, Maniatea A, Koubouni K, Parikakis E, Mitropoulos P. Intravitreal ranibizumab for retinal arterial macroaneurysm: long-term results of a prospective study. European journal of ophthalmology. 2017;27:215–219.

Chatziralli IP, Sergentanis TN, Sivaprasad S. The effect of vitreous on proliferative diabetic retinopathy and the response to panretinal photocoagulation. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:423.

Chatziralli IP, Sergentanis TN, Parikakis EA, Papazisis LE, Mitropoulos P, Moschos MM. The impact of non-steroidal anti-inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and therapy. 2017;6:133–140.

Chatziralli I, Mitropoulos PG, Niakas D, Labiris G. Thyroidopathy and age-related macular degeneration: is there any correlation. Biomedicine hub. 2017;2:1–3.

Chatziralli IP, Sharma PK, Sivaprasad S. Treatment modalities for idiopathic macular telangiectasia: an evidence-based systematic review of the literature. In: Seminars in ophthalmology. Vol. 32. Taylor & Francis; 2017. pp. 384–394.

Chatziralli I, Theodossiadis G, Grigoropoulos V, Datseris I, Chatzirallis A, Theodossiadis P. Comparison of macular findings due to vitreomacular traction alone or in association with epiretinal membrane. European journal of ophthalmology. 2017;27:86–92.

Chatziralli I, Theodossiadis G, Datseris I, Parikakis E, Theodossiadis P. Anatomical and Functional Changes in the Coexistence of Vitreomacular Traction and Epiretinal Membrane: A Spectral-Domain Optical Coherence Tomography Study. Ophthalmic research. 2017;57:54–59.

Chatziralli I, Mitropoulos P, Parikakis E, Niakas D, Labiris G. Risk factors for poor quality of life among patients with age-related macular degeneration. In: Seminars in ophthalmology. Vol. 32. Taylor & Francis; 2017. pp. 772–780.

Moschos MM, Chatziralli IP, Stamatakis G, Papakonstantinou VD, Tsatsos M, Demopoulos CA. In vitro effects of anti-glaucomatous eye drops on platelet-activating factor and its metabolism. In: Seminars in ophthalmology. Vol. 32. Taylor & Francis; 2017. pp. 198–203.

Chatziralli I, Theodossiadis G, Panagiotidis D, Emfietzoglou I, Grigoropoulos V, Theodossiadis P. Long-term changes of macular thickness after pars plana vitrectomy in optic disc pit maculopathy: a spectral-domain optical coherence tomography study. In: Seminars in ophthalmology. Vol. 32. Taylor & Francis; 2017. pp. 302–308.